UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027985
Receipt number R000032049
Scientific Title Nivolumab maintenance as monotherapy after carboplatine plus nab-paclitaxel for first-line treatment of advanced Non-small-cell lung cancer: Feasibility study
Date of disclosure of the study information 2017/07/31
Last modified on 2017/08/01 09:34:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Nivolumab maintenance as monotherapy after carboplatine plus nab-paclitaxel for first-line treatment of advanced Non-small-cell lung cancer: Feasibility study

Acronym

Feasibility Study of nivolumab maintenance therapy

Scientific Title

Nivolumab maintenance as monotherapy after carboplatine plus nab-paclitaxel for first-line treatment of advanced Non-small-cell lung cancer: Feasibility study

Scientific Title:Acronym

Feasibility Study of nivolumab maintenance therapy

Region

Japan


Condition

Condition

Non-Small Cell Lung Cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine recommended dose and cycles of carboplatine plus nab-paclitaxel for nivolumab maintenance therapy in non-small-cell lung cancer

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Feasibility of nivolumab maintenance therapy after carboplatine plus nab-paclitaxel

Key secondary outcomes

Anti-tumor efficacy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Level 1:carboplatin AUC 6+nab-paclitaxel,4cycles
Level 0:carboplatin AUC 5+nab-paclitaxel,3cycles

If 3 or more of the first 6 patients who had been originally allocated to the level 1 experienced nivolumab-induced grade 3-4 toxicity, additinal 6 patients were enrolled to the level 0. If 2 or less of the first 6 patients in level 1 who had experienced nivolumab-induced grade 3-4 toxicity,additinal 6 patients were enrolled to the level 1.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Histology/cytology-proven non-small cell lung cancer
2)No prior treatment
3)Stage IIIB, IV and unsuitable for radiotherapy
4)EGFR(-),ALK(-)
5)PD-L1 staining:1%-49%
6)With one or more measurable disease based on RECIST
7)Performance status(ECOG): 0-1
8)Age 20<80
9)Adequate organ function
10)Written informed consent

Key exclusion criteria

1) Interstitial pneumonia/lung fibrosis on chest X-ray
2) History of chest radiation therapy
3) Auto-immuno disease patients
4) Receiving steroid therapy
5) Symptomatic brain metastasis
6) Active hepatic disease
7) Having serious complications
8) Uncontrolled ascites, pleural effusion or cardiac effusion
9) History of multiple malignancies within 3 years
10) Planning of surgery during the trial
11) A pregnant woman, a nursing girl and woman with the possibility (intention) of the pregnancy, and
12) Having serious mental disorder
13) Previous drug allergy
14) Those judged to be not suitable by the attending physician

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masao Ichiki

Organization

National Hospital Organization Kyushu Medical Center

Division name

Department of Respiratory Medicine

Zip code


Address

1-8-1 Jigyohama Chuo-ku, Fukuoka 810-8563, Japan

TEL

092-852-0700

Email

ichiki@kyumed.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masao Ichiki

Organization

National Hospital Organization Kyushu Medical Center

Division name

Department of Respiratory Medicine

Zip code


Address

1-8-1 Jigyohama Chuo-ku, Fukuoka 810-8563, Japan

TEL

092-852-0700

Homepage URL


Email

ichiki@kyumed.jp


Sponsor or person

Institute

National Hospital Organization Kyushu Medical Center,Department of Respiratory Medicine

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Kyushu Medical Center,Department of Respiratory Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 06 Month 28 Day

Date of IRB


Anticipated trial start date

2017 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 28 Day

Last modified on

2017 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032049


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name